Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Clinical trial NCT06229210 · RECRUITING
Trial details
- NCT number
- NCT06229210
- Sponsor
- Intra-Cellular Therapies, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-25
- Primary completion
- 2032-04-28
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.